Scarica l'app Stockscreener
14.84
3.38%
0.485
Dopo l'orario di chiusura:
14.84
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Delcath Systems Inc Borsa (DCTH) Ultime notizie
Delcath Systems, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - simplywall.st
Delcath Systems targets 30 active centers by year-end 2025 amid strong Q1 performance - MSN
Delcath Systems First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | DCTH Stock News - GuruFocus
Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo
Delcath Systems, Inc. (NASDAQ:DCTH) Q1 2025 Earnings Call Transcript - Insider Monkey
Delcath Systems (NASDAQ:DCTH) delivers shareholders stellar 45% CAGR over 3 years, surging 19% in the last week alone - simplywall.st
Delcath Systems Reports First Quarter 2025 Results and Business Highlights - BioSpace
Delcath Systems Inc (DCTH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Massive Stock Purchases Signal Confidence in Delcath Systems - TipRanks
Delcath Systems’ Earnings Call Highlights Growth and Challenges - TipRanks
Delcath Systems (DCTH) Reports Strong Q1 2025 Results, Eyes Expansion - GuruFocus
Delcath Systems, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Earnings call transcript: Delcath Systems beats Q1 2025 forecasts, shares rise - Investing.com
Delcath (DCTH) Reports Strong Q1 Revenue Surpassing Expectations | DCTH Stock News - GuruFocus
Delcath Systems, Inc. (DCTH) Misses Q1 Earnings Estimates - Yahoo Finance
Delcath Systems earnings beat, revenue topped estimates - Investing.com
Delcath Systems Inc (DCTH) Q1 2025 Earnings: EPS of $0.03 Beats Estimate, Revenue Surges to $19.8 Million - GuruFocus
Delcath Systems (DCTH) Surpasses Q1 Earnings and Revenue Expectations - GuruFocus
Delcath Systems Reports First Quarter 2025 Results and Business Highlights | DCTH Stock News - GuruFocus
Delcath Systems Reports Strong Q1 2025 Growth - TipRanks
Delcath Systems, Inc. (NASDAQ:DCTH) Shares Purchased by Barclays PLC - Defense World
(DCTH) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Analysts Offer Insights on Healthcare Companies: Delcath Systems (DCTH), Repligen (RGEN) and CareDx (CDNA) - The Globe and Mail
FDA clears Delcath’s Phase 2 trial for breast cancer treatment By Investing.com - Investing.com South Africa
FDA clears Delcath’s Phase 2 trial for breast cancer treatment - Investing.com Australia
Delcath Systems Gets FDA Clearance to Start Phase 2 Trial of Hepzato for Metastatic Breast Cancer - marketscreener.com
Delcath Systems (DCTH) Cleared by FDA to Start Phase 2 Trial for Hepzato | DCTH Stock News - GuruFocus
Eagle Financial Services, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
FDA Green Lights Delcath's Breakthrough Liver Cancer Tech Expansion into Breast Cancer Market - Stock Titan
Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer - The Joplin Globe
Geode Capital Management LLC Buys 37,056 Shares of Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World
Financial Metrics Unveiled: Delcath Systems Inc (DCTH)’s Key Ratios in the Spotlight - DWinneX
Delcath Systems Inc (DCTH) shows promising results - uspostnews.com
Liver Cancer Treatment Leader Delcath Systems to Report Q1 2025 Earnings May 8 - Stock Titan
(DCTH) Proactive Strategies - news.stocktradersdaily.com
Moffitt-Led International Study Finds New Drug Delivery System Effective Against Rare Eye Cancer - Central Florida Health News
Delcath Systems (DCTH) Soars 9.8%: Is Further Upside Left in the Stock? - Nasdaq
Delcath Systems Announces Publication of Comparative Analysis fr - GuruFocus
Clinical Data: Delcath's Melanoma Treatment Achieves 175% Better Survival Than Standard Care - Stock Titan
How To Trade (DCTH) - news.stocktradersdaily.com
Pheochromocytoma Treatment Market Size in 7MM is expected - openPR.com
Hospitals Experience FOMO In Adopting Delcath’s PHP Treatment (NASDAQ:DCTH) - Seeking Alpha
Delcath Systems, Inc. (NASDAQ:DCTH) Is Expected To Breakeven In The Near Future - simplywall.st
Charles Schwab Investment Management Inc. Invests $156,000 in Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World
5,470 Shares in Delcath Systems, Inc. (NASDAQ:DCTH) Acquired by Quantbot Technologies LP - Defense World
Delcath Systems (NASDAQ:DCTH) and West Pharmaceutical Services (NYSE:WST) Critical Survey - Defense World
Beta Bionics Announces Board Appointment of Gerard Michel - The Manila Times
Beta Bionics appoints new board member from Delcath Systems By Investing.com - Investing.com South Africa
Beta Bionics appoints new board member from Delcath Systems - Investing.com India
Jim Cramer Blesses Delcath Systems (DCTH): ‘You’re Not Early, But It’s a Win’ - MSN
Jim Cramer Discussed These 6 Stocks Recently - Insider Monkey
Wall Street Analysts See a 58.49% Upside in Delcath Systems (DCTH): Can the Stock Really Move This High? - MSN
Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference - Lelezard
Liver Cancer Treatment Breakthrough? Delcath to Reveal Latest Advances at Major Oncology Conference - Stock Titan
Is aTyr Pharma (ATYR) Stock Outpacing Its Medical Peers This Year? - Nasdaq
Delcath Systems, Inc. (NASDAQ:DCTH) Q4 2024 Earnings Call Transcript - MSN
Delcath Systems awards stock options to new employees By Investing.com - Investing.com Australia
0.11%
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):